A recent study conducted by Dr. med. Michael Winkelmann and his colleagues at the LMU Klinikum München explored the association between TGR dynamics from pre-treatment to post-treatment imaging and the patients' outcomes.
The research provides valuable insights into the potential of TGR as a novel prognostic imaging biomarker in the context of CAR-T therapy for patients with relapsed or refractory non-Hodgkin's lymphoma.
Study with mint Lesion™ Uncovers the Impact of Tumor Growth Rate in Predicting the Efficacy of CAR-T-cell Therapy in Lymphoma Patients
Related Resources
Related Resources
New Technique Speeds Up Whole-Body MRI for Children Without Sacrificing Image Quality, Study Finds
As we mark Childhood Cancer Awareness Month, we would like to highlight the progress achieved in the realm of cancer diagnostics. A recent study led…
Study Discovers Overdiagnosis of Progressive Cancer in Routine Clinical Evaluations
A recent retrospective study led by Dr. Marilyn J. Siegel and her team at the Washington University School of Medicine in St. Louis has shed light on…
University Hospital Jena: Research Investigating the Viability of Accelerating Whole-Body MRI in Children and Adolescents through STIR DWI with Simultaneous Multi-Slice Excitation
This study[1] addressed the challenges of conducting WB-MRI in paediatric patients, particularly the prolonged acquisition time required for…